Results 131 to 140 of about 2,767,476 (321)

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

A tool-supported approach to inter-tabular verification. [PDF]

open access: yes
The use of decision tables to verify KBS has been advocated several times in the V&V literature. However, one of the main drawbacks of those system is that they fail to detect anomalies which occur over rule chains. In a decision table based context this
Vanthienen, Jan   +3 more
core  

Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan   +14 more
wiley   +1 more source

Automated Rule-Checking - a tool for design development

open access: yes, 2016
Although automated rule-checking is often presented in the context of applyingfor licenses and permits, as a way to assess compliance with building codes, its mostimmediate application can be found in earlier stages of the design phase.
João Pedro Poças Martins   +2 more
core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Friction Coefficient Selection of the Robot Travelling Mechanism and Structure Improvement of the Driving Structure

open access: yesJixie chuandong, 2017
The checking of the robot travelling mechanism friction coefficient and a design refinement of the driving structure is carried out based on theoretical calculation and rule of thumb data,facing the creeping phenomenon of the robot travelling mechanism ...
Liao Xiaoji, Fan Qiyong
doaj  

Checking extracted rules in Neural Networks

open access: yes2025 International Joint Conference on Neural Networks (IJCNN)
7 pages, one ...
openaire   +2 more sources

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru   +13 more
wiley   +1 more source

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree   +9 more
wiley   +1 more source

b → c semileptonic sum rule: current status and prospects

open access: yesJournal of High Energy Physics
The b → c semileptonic sum rules provide relations between the decay rates of $$B\to {D}^{(*)}\tau \overline{\nu }$$ and $${\Lambda }_{b}\to {\Lambda }_{c}\tau \overline{\nu }$$ .
Motoi Endo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy